# clm_6BB57BAD5620

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 1,984,164,000 United States dollar  
valid_from: 2021-09-30  
valid_to: 2022-03-31  
published: 2021-11-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_47EA232B8F9C  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 1,984,164,000 United States dollar", as of 2021-09-30 (until 2022-03-31). Claim clm_6BB57BAD5620, https://asof.is/claim/clm_6BB57BAD5620, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532021000033/0000875320-21-000033-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2021, filed 2021-11-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532021000033/0000875320-21-000033-index.htm (primary, SEC EDGAR 10-Q Q3 FY2021, published 2021-11-03)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 1,793,370,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_6BB57BAD5620](/claim/clm_6BB57BAD5620.md) | [clm_BA95AEDBE337](/claim/clm_BA95AEDBE337.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.